1. MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway
    Gang Zhao et al, 2016 CrossRef
  2. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
    Lei Li et al, 2016, Journal of Hepatology CrossRef
  3. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway
    Jiaojiao Gong et al, 2017 CrossRef
  4. Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Shiyu Xiao et al, 2017, Int J Oncol CrossRef
  5. Overexpression of the androgen receptor in human hepatoma cells and its effect on fatty acid metabolism
    Tatsuo Kanda et al, 2017 CrossRef
  6. Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [18F]fluorocholine PET/CT
    Sandi Kwee et al, 2015, Diagnostics CrossRef
  7. Lipid metabolism and lipophagy in cancer
    Meenu Maan et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  8. 1H Nuclear Magnetic Resonance Based Metabolomics Approach Reveals the Metabolic Mechanism of (−)-5-Hydroxy-equol against Hepatocellular Carcinoma Cells in Vitro
    Li Gao et al, 2018, J. Proteome Res. CrossRef
  9. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis.
    Eunjeong Kim et al, 2018, Hepatology CrossRef
  10. Evaluation of Aflatoxin M1 Effects on the Metabolomic and Cytokinomic Profiling of a Hepatoblastoma Cell Line
    Silvia Marchese et al, 2018, Toxins CrossRef
  11. Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
    Hayato Nakagawa et al, 2018, Cancers CrossRef
  12. Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome
    Aparna Prasad et al, 2016, Journal of Investigative Dermatology CrossRef
  13. Validation of R-2-[18F]Fluoropropionic Acid as a Potential Tracer for PET Imaging of Liver Cancer
    Zhanwen Zhang et al, 2019, Mol Imaging Biol CrossRef
  14. The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy
    Tiago MA. Carvalho et al, 2019, European Journal of Medicinal Chemistry CrossRef
  15. Alterations in global DNA methylation and metabolism-related genes caused by zearalenone in MCF7 and MCF10F cells.
    Sibel Özden, 0 CrossRef
  16. Pyridine derivatives as anticancer lead compounds with Fatty Acid Synthase as the target: An in silico-guided in vitro study.
    Nisthul A Amrutha et al, 2019, J Cell Biochem CrossRef
  17. Chemical characterization and cytotoxic potential of an ellagitannin-enriched fraction from Fragaria vesca leaves
    Joana Liberal et al, 2015, Arabian Journal of Chemistry CrossRef
  18. Oncogene dependent requirement of fatty acid synthase in hepatocellular carcinoma
    Li Che et al, 2017, Cell Cycle CrossRef
  19. Emerging roles of lipid metabolism in cancer metastasis.
    Xiangjian Luo et al, 2017, Mol Cancer CrossRef
  20. null
    C. Nelson Hayes et al, 2019 CrossRef
  21. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway
    Wenyue Zhang et al, 2020, Annals of Hepatology CrossRef
  22. A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer
    Li Yang et al, 2016, Oncotarget CrossRef
  23. Non-Coding RNAs Operate in the Crosstalk Between Cancer Metabolic Reprogramming and Metastasis.
    Ziyi Li et al, 2020, Front Oncol CrossRef
  24. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
    Moris Sangineto et al, 2020, Cancers CrossRef
  25. A saturated fatty acid-rich diet enhances steatogenesis and liver tumorigenesis in HCV core gene transgenic mice
    Pan Diao et al, 2020, The Journal of Nutritional Biochemistry CrossRef
  26. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
    Qiuyue Hu et al, 2020, Disease Markers CrossRef
  27. Metabolic heterogeneity of human hepatocellular carcinoma: implications for personalized pharmacological treatment
    Nikolaus Berndt et al, 2020, FEBS J CrossRef
  28. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
    Huai-Peng Lin et al, 0 CrossRef
  29. Classification Technology and Application of Multifunctional Enzymes
    鹏丽 毕, 2021, CSA CrossRef
  30. null
    Witchuda Sukjoi et al, 2021 CrossRef
  31. Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
    Ana Hipólito et al, 2021, Front. Oncol. CrossRef
  32. Role of Lipogenesis Rewiring in Hepatocellular Carcinoma
    Yi Zhou et al, 2021, Semin Liver Dis CrossRef
  33. Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression
    Jittima Tomacha et al, 2021, Front. Pharmacol. CrossRef
  34. USP14 Regulates Cancer Cell Growth in a Fatty Acid Synthase-Independent Manner
    Ji Su Yang et al, 2021, IJMS CrossRef
  35. Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism
    Xuemin Zhong et al, 2022, Front. Oncol. CrossRef
  36. Lipid alterations in chronic liver disease and liver cancer.
    Bichitra Paul et al, 2022, JHEP Rep CrossRef
  37. Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation
    Ming Ding et al, 2022 CrossRef
  38. Metabolic Reprogramming in Cholangiocarcinoma
    Chiara Raggi et al, 2022, Journal of Hepatology CrossRef
  39. High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
    Martijn P.D. Haring et al, 2022, JHEP Reports CrossRef
  40. null
    Shabana Bibi et al, 2022 CrossRef
  41. Identification of lipid metabolism-associated genes as prognostic biomarkers based on the immune microenvironment in hepatocellular carcinoma
    Xiangqian Gu et al, 2022, Front. Cell Dev. Biol. CrossRef
  42. Metabolic programming and immune suppression in the tumor microenvironment
    Emily N. Arner et al, 2023, Cancer Cell CrossRef
  43. Ameliorative Effect of Posidonia oceanica on High Glucose-Related Stress in Human Hepatoma HepG2 Cells
    Marzia Vasarri et al, 2023, IJMS CrossRef
  44. Involvement of the pro-oncogenic enzyme fatty acid synthase in the hallmarks of cancer: a promising target in anti-cancer therapies
    Dimitri Vanauberg et al, 2023, Oncogenesis CrossRef
  45. Metabolic codependencies in the tumor microenvironment and gastric cancer: Difficulties and opportunities
    Xihe Zhao et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  46. Pentacyclic Triterpenes from Olive Leaves Formulated in Microemulsion: Characterization and Role in De Novo Lipogenesis in HepG2 Cells
    Marzia Vasarri et al, 2023, IJMS CrossRef
  47. An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC)
    Bárbara Ferreira et al, 2023, Molecular and Cellular Endocrinology CrossRef
  48. LncRNAs‐circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers
    Shanshan Liu et al, 2023, Advanced Science CrossRef
  49. Advances in Targeted Drug Resistance Associated with Dysregulation of Lipid Metabolism in Hepatocellular Carcinoma
    Xiaoju Huang et al, 2024, JHC CrossRef
  50. Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype
    Davide Gnocchi et al, 2024, Plant Foods Hum Nutr CrossRef